| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 61.70B | 58.55B | 63.98B | 64.13B | 84.22B | 71.50B |
| Gross Profit | 12.35B | 12.10B | 14.24B | 15.23B | 14.72B | 12.61B |
| EBITDA | 3.20B | 2.58B | 5.21B | 6.60B | 5.68B | 3.88B |
| Net Income | 380.00M | -43.00M | 1.89B | 3.23B | 2.77B | 1.37B |
Balance Sheet | ||||||
| Total Assets | 39.68B | 40.10B | 42.55B | 34.23B | 31.18B | 27.48B |
| Cash, Cash Equivalents and Short-Term Investments | 10.90B | 14.25B | 16.46B | 13.43B | 9.81B | 8.89B |
| Total Debt | 8.52B | 9.53B | 10.89B | 4.15B | 4.79B | 5.39B |
| Total Liabilities | 20.85B | 21.49B | 23.47B | 16.31B | 16.24B | 15.07B |
| Stockholders Equity | 17.35B | 17.24B | 17.87B | 16.92B | 14.08B | 11.64B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 26.00M | 1.83B | 4.86B | 2.36B | 3.41B |
| Operating Cash Flow | 0.00 | 980.00M | 2.52B | 5.33B | 3.06B | 3.66B |
| Investing Cash Flow | 0.00 | -1.23B | -5.26B | -644.00M | -1.21B | -531.00M |
| Financing Cash Flow | 0.00 | -2.02B | 5.70B | -1.16B | -1.00B | -1.30B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥20.96B | 15.42 | ― | 4.30% | 9.51% | 22.90% | |
73 Outperform | ¥20.51B | 12.55 | ― | 3.50% | 3.05% | -22.47% | |
73 Outperform | ¥24.67B | 23.70 | ― | 5.65% | 38.75% | -3.18% | |
68 Neutral | ¥23.36B | 17.08 | ― | 4.28% | 1.18% | -5.05% | |
67 Neutral | ¥11.55B | 10.90 | ― | 4.49% | 4.17% | 12.22% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
58 Neutral | ¥17.75B | 20.81 | ― | 3.81% | 8.62% | ― |